Chester County News and Community Website
NEWTOWN, PA — Helius Medical Technologies (NASDAQ: HSDT) has reported promising results from its Stroke Registrational Program (SRP), paving the way for a potential U.S. regulatory submission later this year. …
Helius Medical Reports Positive Trial Results for Stroke Therapy, Eyes FDA Submission Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced this week that it has secured continued listing on the Nasdaq Capital Market after successfully meeting key financial requirements.
Helius Medical Secures Continued Nasdaq Listing After Compliance Win Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced a 1-for-50 reverse split of its Class A common stock, set to take effect at 5:00 pm Eastern time …
Helius Medical Announces 1-for-50 Reverse Stock Split Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced that CignaHealth has authorized claims for payment of the company’s Portable Neuromodulation Stimulator (PoNS) Device. The authorization marks a …
Helius Medical Technologies Secures Fifth Major Payer Authorization for PoNS Device Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (NASDAQ: HSDT) announced encouraging results from its PoNSTEP study, presented at the 2025 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting. The findings …
Helius Shares Positive PoNSTEP Study Results on PoNS Therapy for MS Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced that Aetna Healthcare has authorized a claim for reimbursement for its Portable Neuromodulation Stimulator (PoNS) Device, marking a significant milestone …
Helius Medical Secures Aetna Approval for PoNS Device Reimbursement Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced that on June 3, 2025, it received notice from the Nasdaq Hearings Panel confirming compliance with the minimum bid price …
Helius Medical Secures Nasdaq Bid Price Compliance, Eyes Equity Requirement Deadline Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (NASDAQ: HSDT) will reveal groundbreaking findings from its PoNSTEP study at the 2025 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting, taking place …
Helius Medical Technologies to Present Breakthrough PoNS Study Results at CMSC Annual Meeting Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced that United Healthcare, one of the largest healthcare providers in the United States, has approved reimbursement for the company’s …
Helius Medical Technologies Secures Key Reimbursement Approval for PoNS Device Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced the creation of Revelation Neuro, Inc., a wholly owned private subsidiary dedicated to developing non-implantable AI-powered brain-computer interface (BCI) technology. …
Helius Medical Unveils Revelation Neuro to Pioneer AI-Powered Neurorehabilitation Read More